MMIT’s Pulse Analytics solution offers actionable data to power your IDN commercial strategy
As integrated delivery networks (IDNs) continue to grow in size and scope, it’s critical that pharma manufacturers target these key accounts, yet finding the right data to inform a robust IDN commercial strategy can seem like an insurmountable obstacle.
MMIT’s Pulse Analytics solution provides one of the most comprehensive and granular data sets to help pharma companies get the actionable insights they need to target these critical accounts.
Pulse Analytics enables pharma companies to:
With our comprehensive data solution, you’ll gain insights into:
Pulse Analytics provides actionable data and valuable insights on an intuitive, user-friendly platform.
Pulse Provider: Offers indication-specific insights on internally developed pathways and key provider account profiles, and includes a decision maker map and regional footprint
Pulse Pathways: Offers indication-specific insights on third-party clinical pathway adoption, institution protocols, brand positioning, key influencers and adoption/mix
The Power of Partnerships: Why Pharma Needs to Redefine its Role With IDNs As IDNs continue to expand their reach and influence, it’s time for pharma companies to rethink their one-size-fits-all approach to IDN engagement. Here’s how.READ ARTICLE
MMIT has partnered with The Dedham Group to offer premier advisory services to oncology clients looking to improve their IDN commercial strategies.LEARN MORE